• Vanda Pharmaceuticals' (VNDA) "Buy" Rating Reaffirmed at HC Wainwright

    Source: Buzz FX / 28 Jan 2025 08:11:18   America/New_York


    Vanda Pharmaceuticals' (VNDA) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat January 28, 2025 Share Link copied to clipboard. Vanda Pharmaceuticals ( NASDAQ:VNDA - Get Free Report ) 's stock had its "buy" rating reiterated b
    Read more...
Share on,